BIOWEG has raised €16M in a Series A round led by Axeleo Capital to scale biodegradable alternatives to microplastics. The funding will support their first industrial bacterial cellulose plant in Germany.

Sep 16, 2025•11 days ago

Amount Raised

€16 Million

Round Type

series a

QuakenbrueckBiotechnology

Investors

Dr. Ing. Frank JennerBon VentureN Bank CapitalEic FundAxeleo Capital

Description

BIOWEG, a German biotechnology company, has closed a €16 million Series A round. The funding will support the scaleup, commercialisation, and construction of their bacterial cellulose plant in Germany. The round was led by Axeleo Capital and included several notable investors. This financing enables BIOWEG to advance its production capabilities to meet the demand for sustainable ingredients.

Company Information

Company

BIOWEG

Location

Quakenbrueck, Niedersachsen, Germany

About

BIOWEG is a German biotechnology company focused on developing high-performance, biodegradable ingredients to replace microplastics in various industries. Founded in 2019, it utilizes food-industry side streams and precision fermentation to create bacterial cellulose alternatives to fossil-based polymers. The company is expanding its production capabilities to meet the growing demand for sustainable ingredients. BIOWEG operates a pilot plant and a formulation lab, positioning itself as a leader in the transition towards microplastic-free products.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends